We conducted a randomized trial involving @ patients at high risk for cardiovascular events who had LDL cholesterol levels of @ mg per deciliter ( @ mmol per liter ) or more and were receiving treatment with statins at the maximum tolerated dose ( the highest dose associated with an acceptable side-effect profile ) , with or without other lipid-lowering therapy .